InvestorsHub Logo
Followers 87
Posts 4052
Boards Moderated 0
Alias Born 07/08/2020

Re: None

Sunday, 10/01/2023 5:49:50 PM

Sunday, October 01, 2023 5:49:50 PM

Post# of 9827
THER

“In preparation for the trial and other pipeline developments, the Company has taken measures to clean its balance sheet, including recently retiring $900,000 in convertible, floorless debt. Management is currently in negotiations with its lenders and accredited investors to secure additional funding structured under attractive terms, including preferred stock and fixed-rate convertible debentures.”

https://www.otcmarkets.com/stock/THER/news/OncBioMune-Initiates-Phase-2-Clinical-Trial-of-Novel-Vaccine-as-Front-Line-Treatment-for-Prostate-Cancer?id=205204
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent THER News